$27.42 -1.80 (-6.16%) Akorn Inc - NASDAQ

Sep. 26, 2016 | 04:00 PM
Last Trade: 27.42
Trade Time: Sep 26 04:00 PM Eastern Daylight Time
Change: -1.80 (-6.16%)
Prev Close: 29.22
Open: 28.95
Bid: 27.42
Ask: 27.43
  1. No results found.
  1. Stocks Remain Indecisive; Jack In The Box, Fitbit Score Big Gains

    Investors Business Daily | Aug. 4, 2016 | 15:29PM EST
  2. Stock Futures Up, Europe Rallies On BOE Vote; Monster On Deck

    Investors Business Daily | Aug. 4, 2016 | 08:58AM EST
  3. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  4. Top-Notch Funds Buying Constellation, Northrop Grumman

    IBD | Jan. 8, 2016 | 17:56PM EST
  5. Piper Jaffray: Akorn's Stock Will Be Delisted In 2016

    Benzinga | Dec. 18, 2015 | 11:18AM EST
  6. Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

    Benzinga | Dec. 18, 2015 | 10:52AM EST
  7. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Oct. 27, 2015 | 04:23AM EST
  8. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD | Oct. 6, 2015 | 13:23PM EST
  9. Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

    Benzinga | Sep. 17, 2015 | 07:00AM EST
  10. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 14:48PM EST
  11. Akorn's

    IBD | Aug. 4, 2015 | 18:41PM EST
  12. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 13:08PM EST
  13. 5 Mid-Caps With Unsustainable Cash Burn Rates

    Benzinga | Jul. 27, 2015 | 09:23AM EST
  14. Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral

    Benzinga | Jul. 21, 2015 | 11:31AM EST
  15. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Jun. 19, 2015 | 04:43AM EST
Trading Center